Daniel P Getman insider trades: Sucampo Pharmaceuticals (SCMP) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 29, 2016 | SCMP | ↓ Sell | 20,000 | $16.86 | $337K | Direct | Nov 30, 2016 (1d) |
| Aug 28, 2015 | SCMP | ↓ Sell | 30,000 | $28.14 | $844K | Direct | Aug 31, 2015 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel P Getman's insider trades
Daniel P Getman is a director at Sucampo Pharmaceuticals (SCMP). Since Aug 28, 2015, Daniel has reported no open-market purchases and 2 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SCMP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.